Diethylene Glycol Monoethyl Ether

Diethylene Glycol Monoethyl Ether

SCHEMBL2534798

C=CC.CCOCCOCCO.OCCO

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
TSHR P16473 6/20 0.46
MAPK1 P28482 2/20 0.46
THRB P10828 2/20 0.45
HTT P42858 1/20 0.45
MAPT P10636 1/20 0.45
TP53 P04637 2/20 0.32
HIF1A Q16665 2/20 0.32
HSD17B10 Q99714 1/20 0.32
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
CASP1 P29466 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLCO1B3 Q9NPD5 1/20 0.31
SLCO1B1 Q9Y6L6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylene Glycol Monoethyl Ether SCHEMBL15135606 0.98 ALDH1A1 (0.67) ALDH1A1MEN1KMT2ATSHRMAPK1
Ethylene Glycol SCHEMBL17435069 0.95 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ATSHRMAPK1
2-Ethoxyethanol SCHEMBL6545845 0.95 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATSHRMAPK1
2-Ethoxyethanol SCHEMBL28745967 0.93 ALDH1A1 (0.74) ALDH1A1MEN1KMT2ATSHRMAPK1
2-Ethoxyethanol SCHEMBL16553503 0.93
Tetraethylene Glycol SCHEMBL5829877 0.91 MEN1 (0.61) ALDH1A1MEN1KMT2ATSHRMAPK1
Tetraethylene Glycol SCHEMBL5380779 0.91 MEN1 (0.61) ALDH1A1MEN1KMT2ATSHRMAPK1
Triethylene Glycol SCHEMBL3454399 0.91 MEN1 (0.61) ALDH1A1MEN1KMT2ATSHRMAPK1
Triethylene Glycol SCHEMBL3424101 0.91 MEN1 (0.61) ALDH1A1MEN1KMT2ATSHRMAPK1
Triethylene Glycol SCHEMBL4864976 0.90 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980309-B2 Transdermal testosterone formulation for minimizing skin residues ANTARES PHARMA IPL AG (CH) 2015-03-17 US disclosed
US-20110257141-A1 TRANSDERMAL PHARMACEUTICAL FORMULATION FOR MINIMIZING SKIN RESIDUES ANTARES PHARMA, IPL, AG 2011-10-20 US disclosed
US-7335379-B2 Transdermal pharmaceutical formulation for minimizing skin residues ANTARES PHARMA IPL AG (CH) 2008-02-26 US disclosed
US-20060153905-A1 Transdermal pharmaceutical formulation for minimizing skin residues ANTARES PHARMA, INC. 2006-07-13 US disclosed